Medpace Holdings, Inc. MEDP Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.68B+24.2% | $2.53B+20.0% | $2.36B+13.9% | $2.23B+9.9% | $2.16B+9.9% | ||
| $187.58M-3.3% | $197.56M+9.6% | $198.08M+11.7% | $199.21M+17.6% | $194M+15.9% | ||
| $865K-34.4% | $946K-34.4% | $1.07M-34.4% | $1.19M-34.4% | $1.32M-34.4% | ||
| $2.12B+24.4% | $2B+20.0% | $1.85B+11.4% | $1.75B+6.4% | $1.7B+5.7% | ||
| $562.92M+23.4% | $534.94M+19.7% | $507.04M+24.0% | $477.51M+25.2% | $456.32M+28.7% | ||
| 21%-0.1pp | 21.1%0.0pp | 21.5%+1.8pp | 21.4%+2.6pp | 21.2%+3.1pp | ||
| $11.43M-58.2% | $12.78M-48.9% | $16.94M— | $22.95M— | $27.34M— | ||
| $8.88M-64.4% | $7.44M-74.4% | $12.38M— | $17.86M— | $24.99M— | ||
| $571.8M+18.8% | $542.38M+14.0% | $519.43M+20.0% | $495.37M+24.7% | $481.31M+32.8% | ||
| $111.4M+71.6% | $91.25M+27.6% | $86.42M+28.8% | $77.07M+34.3% | $64.92M+30.0% | ||
| $460.4M+10.6% | $451.12M+11.6% | $433.01M+18.4% | $418.3M+23.1% | $416.39M+33.2% | ||
| 17.2%-2.1pp | 17.8%-1.3pp | 18.4%+0.7pp | 18.7%+2.0pp | 19.3%+3.4pp | ||
| $15.88+21.2% | $15.27+20.9% | $14.30+25.2% | $13.45+26.5% | $13.10+33.5% | ||
| $16.22+20.1% | $15.64+19.8% | $14.66+23.9% | $13.82+25.4% | $13.51+32.8% | ||
| 116.4M-8.6% | 118.7M-7.4% | 121.2M-5.3% | 124.4M-2.5% | 127.4M+0.2% | ||
| 114M-7.6% | 116M-6.4% | 118.1M-4.5% | 121M-1.8% | 123.4M+0.5% | ||
| $1.9B+28.6% | $1.77B+21.8% | $1.62B+11.6% | $1.53B+5.2% | $1.48B+4.5% | ||
| $11.43M-58.2% | $12.78M-48.9% | $16.94M— | $22.95M— | $27.34M— | ||
| $865K-34.4% | $946K-34.4% | $1.07M-34.4% | $1.19M-34.4% | $1.32M-34.4% | ||
| $27.24M-2.3% | $27.18M-2.3% | $27.43M+1.3% | $27.77M+5.8% | $27.87M+9.9% | ||
| -$2.55M-8.4% | -$5.34M-232% | -$4.56M— | -$5.1M— | -$2.35M— | ||
| $2.68B+24.2% | $2.53B+20.0% | $2.36B+13.9% | $2.23B+9.9% | $2.16B+9.9% | ||
| $562.92M+23.4% | $534.94M+19.7% | $507.04M+24.0% | $477.51M+25.2% | $456.32M+28.7% | ||
| $591.02M+21.7% | $563.06M+18.3% | $535.54M+22.4% | $506.48M+23.7% | $485.51M+27.1% | ||
| $591.02M+21.7% | $563.06M+18.3% | $535.54M+22.4% | $506.48M+23.7% | $485.51M+27.1% | ||
| 22.1%-0.4pp | 22.3%-0.3pp | 22.7%+1.6pp | 22.7%+2.5pp | 22.5%+3.0pp | ||
| $562.92M+23.4% | $534.94M+19.7% | $507.04M+24.0% | $477.51M+25.2% | $456.32M+28.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Medpace Holdings, Inc.'s revenue?
- Medpace Holdings, Inc. (MEDP) generated $2.7B in revenue over the trailing twelve months, up 24.2% year over year.
- Is Medpace Holdings, Inc. profitable?
- Medpace Holdings, Inc. reported $460.4M in net income over the trailing twelve months, a 17.2% net margin.
- What is Medpace Holdings, Inc.'s earnings per share?
- Medpace Holdings, Inc.'s diluted EPS over the trailing twelve months is $15.88.
- Where does Medpace Holdings, Inc.'s income statement data come from?
- Every line is extracted from Medpace Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
